Rina Bandopadhyay

Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology

Affiliated withUCL Institute of Neurology

Research Area

Biography

Rina Bandopadhyay has not added Biography.
If you are Rina Bandopadhyay and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 46	2016

Other Publications

Article	Year
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain : a journal of neurology\| PubMed ID: 14662519	2004
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition. Neurobiology of disease\| PubMed ID: 15894486	2005
Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein. Neuroscience letters\| PubMed ID: 15955416	2005
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiology of disease\| PubMed ID: 16750377	2006
DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders. Neurobiology of disease\| PubMed ID: 17719794	2007
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neuroscience letters\| PubMed ID: 19146923	2009
TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing. Acta neuropathologica\| PubMed ID: 19330339	2009
Differential DJ-1 gene expression in Parkinson's disease. Neurobiology of disease\| PubMed ID: 19716892	2009
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends in molecular medicine\| PubMed ID: 20036196	2010
Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model. Movement disorders : official journal of the Movement Disorder Society\| PubMed ID: 20818670	2010
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain : a journal of neurology\| PubMed ID: 21752791	2011
Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. Acta neuropathologica\| PubMed ID: 21773886	2011
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PloS one\| PubMed ID: 21799870	2011
Transportin1: a marker of FTLD-FUS. Acta neuropathologica\| PubMed ID: 21847626	2011
α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22065755	2011
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations. PloS one\| PubMed ID: 23082216	2012
AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease. Human molecular genetics\| PubMed ID: 23393160	2013
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Neurobiology of aging\| PubMed ID: 23664753	2013
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases. Neurobiology of disease\| PubMed ID: 23747310	2013
Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochimica et biophysica acta\| PubMed ID: 23916833	2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. PloS one\| PubMed ID: 23967090	2013
Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochemical and biophysical research communications\| PubMed ID: 24211199	2013
Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily. Human molecular genetics\| PubMed ID: 24282027	2014
GTP binding controls complex formation by the human ROCO protein MASL1. The FEBS journal\| PubMed ID: 24286120	2014
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease. Neurobiology of aging\| PubMed ID: 24300239	2014
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Human molecular genetics\| PubMed ID: 24740878	2014
A crucial role for DOK1 in PDGF-BB-stimulated glioma cell invasion through p130Cas and Rap1 signalling. Journal of cell science\| PubMed ID: 24762811	2014
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Human molecular genetics\| PubMed ID: 24794857	2014
Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution. The Journal of biological chemistry\| PubMed ID: 24942733	2014
Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions. Acta neuropathologica communications\| PubMed ID: 25403864	2014
Cellular processes associated with LRRK2 function and dysfunction. The FEBS journal\| PubMed ID: 25899482	2015
LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5. Biochemistry\| PubMed ID: 26268594	2015
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain. Journal of neurochemistry\| PubMed ID: 26375402	2015